Cryo‐ EM structures of engineered Shiga toxin‐based immunogens capable of eliciting neutralizing antibodies with therapeutic potential against hemolytic uremic syndrome
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Alejandro Ezequiel Cristófalo, Arvind Sharma, María Laura Cerutti, Kedar Sharma, Roberto Melero, Romina Pardo, Fernando Alberto Goldbaum, Mario Borgnia, Vanesa Zylberman, Lisandro Horacio Otero |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2025
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Ischemic colitis complicated by Shiga toxin‐producing Escherichia coli hemolytic uremic syndrome
by: Shohei Yoshimura, et al.
Published: (2026)
by: Shohei Yoshimura, et al.
Published: (2026)
A phase I study to evaluate the safety, tolerance and pharmacokinetics of anti‐Shiga toxin hyperimmune equine F (ab′)2 fragments in healthy volunteers
by: Yanina Hiriart, et al.
Published: (2024)
by: Yanina Hiriart, et al.
Published: (2024)
Atypical hemolytic-uremic syndrome (aHUS)
by: Gustavo Adolfo Domínguez-Ramírez
Published: (2019)
by: Gustavo Adolfo Domínguez-Ramírez
Published: (2019)
Neutralizing antibodies in the intestinal mucosa are essential to control gastrointestinal infection by Shiga toxin‐producing Escherichia coli
by: Alan Mauro Bernal, et al.
Published: (2025)
by: Alan Mauro Bernal, et al.
Published: (2025)
Hemolytic uremic syndrome without diarrhea in an infant due to non‐ O157 Shiga toxin‐producing enterohemorrhagic Escherichia coli
by: Hiroki Yoshihara, et al.
Published: (2026)
by: Hiroki Yoshihara, et al.
Published: (2026)
De-N-acetylated sialic acid is immunogenic and elicits antibodies that are protective against Neisseria meningitidis
by: Gregory R. Moe
Published: (2009)
by: Gregory R. Moe
Published: (2009)
MXene confined microcapsules for uremic toxins elimination
by: Xiaomin Ye, et al.
Published: (2024)
by: Xiaomin Ye, et al.
Published: (2024)
Correction to “Neutralizing antibodies In the intestinal mucosa are essential to control gastrointestinal infection by Shiga toxin‐producing Escherichia coli ”
Published: (2025)
Published: (2025)
Atypical hemolytic‐uremic syndrome after COVID‐19 vaccine: A case report
by: Marcos Adriano Garcia Campos, et al.
Published: (2024)
by: Marcos Adriano Garcia Campos, et al.
Published: (2024)
Bisphenol (A) uremic toxin to take into account in the Renal disease in Hemodialysis
by: Enrique Bosch-Panadero
Published: (2017)
by: Enrique Bosch-Panadero
Published: (2017)
EP11.19: A rare presentation: suspected hemolytic uremic syndrome in early pregnancy
by: N. Zhiri, et al.
Published: (2024)
by: N. Zhiri, et al.
Published: (2024)
Diffuse alveolar haemorrhage due to atypical hemolytic uremic syndrome (aHUS) associated with COVID‐19
by: Atif Siddiqui, et al.
Published: (2024)
by: Atif Siddiqui, et al.
Published: (2024)
Isolated abducens nerve palsy treated by immunoadsorption in a patient with diarrhea-associated hemolytic uremic syndrome
by: Sibel Ersan
Published: (2018)
by: Sibel Ersan
Published: (2018)
Isolated abducens nerve palsy treated by immunoadsorption in a patient with diarrhea-associated hemolytic uremic syndrome
by:
Published: (2018)
by:
Published: (2018)
An approximate graph elicits detonation lattice
by: Sharma, Vansh, et al.
Published: (2026)
by: Sharma, Vansh, et al.
Published: (2026)
Atypical hemolytic uremic syndrome during induction chemotherapy in neuroblastoma, a rare phenomenon or common congenital predisposition?
by: Meghan Davitt, et al.
Published: (2024)
by: Meghan Davitt, et al.
Published: (2024)
O que fazer com os conteúdos?... uma análise
by: Moisés Goldbaum
Published: (2005)
by: Moisés Goldbaum
Published: (2005)
Utilização de serviços de saúde em áreas cobertas pelo programa saúde da família (Qualis) no Município de São Paulo
by: Moisés Goldbaum
Published: (2005)
by: Moisés Goldbaum
Published: (2005)
Grouped immunogens are hierarchically recognized by host to generate antibodies.
by: Liu, Xiang, et al.
Published: (2026)
by: Liu, Xiang, et al.
Published: (2026)
Evaluating AI cyber capabilities with crowdsourced elicitation
by: Petrov, Artem, et al.
Published: (2025)
by: Petrov, Artem, et al.
Published: (2025)
Successful 13‐year ongoing remission with C5 inhibitor therapy following renal transplant in atypical hemolytic uremic syndrome
by: Mariam A. Mostafa, et al.
Published: (2024)
by: Mariam A. Mostafa, et al.
Published: (2024)
Data‐driven evaluation of suitable immunogens for improved antibody selection
by: Katharina Waury, et al.
Published: (2025)
by: Katharina Waury, et al.
Published: (2025)
Diagnostic oriented discrimination of different Shiga toxins via PCA‐assisted SERS‐based plasmonic metasurface
by: Massimo Rippa, et al.
Published: (2025)
by: Massimo Rippa, et al.
Published: (2025)
Survival of Shiga toxin-producing Escherichia coli O157:H7 in Minas frescal cheese
by: Jesieli Braz FROZI
Published: (2015)
by: Jesieli Braz FROZI
Published: (2015)
Discovery of broadly‐neutralizing antibodies against brown recluse spider and Gadim scorpion sphingomyelinases using consensus toxins as antigens
by: Esperanza Rivera‐de‐Torre, et al.
Published: (2024)
by: Esperanza Rivera‐de‐Torre, et al.
Published: (2024)
Molecular screening of bovine raw milk for the presence of Shiga toxin-producing Escherichia coli (STEC) on dairy farms
by: Tatiane VENDRAMIN
Published: (2014)
by: Tatiane VENDRAMIN
Published: (2014)
Coupling enterotoxigenic Escherichia coli heat‐stable peptide toxin with 8‐arm PEG enhances immunogenicity
by: Ephrem Debebe Zegeye, et al.
Published: (2024)
by: Ephrem Debebe Zegeye, et al.
Published: (2024)
Loss of PTPRS elicits potent metastatic capability and resistance to temozolomide in glioblastoma
by: Yihua Zhang, et al.
Published: (2024)
by: Yihua Zhang, et al.
Published: (2024)
Optimización del Soporte Ventilatorio del Donante Pulmonar. Revisión Bibliográfica
by: Vanesa Romina Ruiz
Published: (2017)
by: Vanesa Romina Ruiz
Published: (2017)
A review of conditions influencing fate of Shiga toxin‐producing Escherichia coli O157:H7 in leafy greens
by: Joshua Ombaka Owade, et al.
Published: (2024)
by: Joshua Ombaka Owade, et al.
Published: (2024)
Validation and use of the dead‐end ultrafiltration method for the capture and recovery of Shiga toxin‐producing Escherichia coli from surface water
by: Ai Kataoka, et al.
Published: (2025)
by: Ai Kataoka, et al.
Published: (2025)
Drug-like antibodies with low immunogenicity in human panels designed with Latent-X2
by: Latent Labs Team, et al.
Published: (2025)
by: Latent Labs Team, et al.
Published: (2025)
Erythrocyte membrane‐coated nanoparticles with toxin neutralization and antimicrobial activity
by: Kan Hu, et al.
Published: (2025)
by: Kan Hu, et al.
Published: (2025)
Fast Laplace transforms on quantum computers
by: Zylberman, Julien
Published: (2024)
by: Zylberman, Julien
Published: (2024)
Sacrificar al extranjero
by: Lior Zylberman
Published: (2013)
by: Lior Zylberman
Published: (2013)
Utilidad del cisplatino intrapericárdico en el tratamiento del derrame pericárdico maligno
by: Marcelo Zylberman
Published: (2010)
by: Marcelo Zylberman
Published: (2010)
La confusión. El caso Demjanjuk y la representación del Holocausto
by: Lior Zylberman
Published: (2024)
by: Lior Zylberman
Published: (2024)
“Debordering” public health: the changing patterns of health border in modern Europe
by: Patrick Zylberman
Published: (2020)
by: Patrick Zylberman
Published: (2020)
Incidencia y mortalidad de la hiponatremia en pacientes con cáncer.
by: Marcelo Zylberman
Published: (2010)
by: Marcelo Zylberman
Published: (2010)
José Emilio Burucúa y Nicolás Kwiatkowski, “Cómo sucedieron estas cosas”. Representar masacres y genocidios, Buenos Aires, Katz, 2014, 297 páginas
by: Lior Zylberman
Published: (2015)
by: Lior Zylberman
Published: (2015)
Similar Items
-
Ischemic colitis complicated by Shiga toxin‐producing Escherichia coli hemolytic uremic syndrome
by: Shohei Yoshimura, et al.
Published: (2026) -
A phase I study to evaluate the safety, tolerance and pharmacokinetics of anti‐Shiga toxin hyperimmune equine F (ab′)2 fragments in healthy volunteers
by: Yanina Hiriart, et al.
Published: (2024) -
Atypical hemolytic-uremic syndrome (aHUS)
by: Gustavo Adolfo Domínguez-Ramírez
Published: (2019) -
Neutralizing antibodies in the intestinal mucosa are essential to control gastrointestinal infection by Shiga toxin‐producing Escherichia coli
by: Alan Mauro Bernal, et al.
Published: (2025) -
Hemolytic uremic syndrome without diarrhea in an infant due to non‐ O157 Shiga toxin‐producing enterohemorrhagic Escherichia coli
by: Hiroki Yoshihara, et al.
Published: (2026)